Gary M. Onady

1.1k total citations · 1 hit paper
22 papers, 703 citations indexed

About

Gary M. Onady is a scholar working on General Health Professions, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gary M. Onady has authored 22 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in General Health Professions, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gary M. Onady's work include Health Sciences Research and Education (9 papers), Meta-analysis and systematic reviews (7 papers) and Cystic Fibrosis Research Advances (7 papers). Gary M. Onady is often cited by papers focused on Health Sciences Research and Education (9 papers), Meta-analysis and systematic reviews (7 papers) and Cystic Fibrosis Research Advances (7 papers). Gary M. Onady collaborates with scholars based in United States. Gary M. Onady's co-authors include Adrienne Stolfi, Karen A. Robinson, Bruce C. Marshall, Marcia Katz, Kathryn A. Sabadosa, Carol Brunzell, Richard Cohen, Arlene A. Stecenko, Bonnie Slovis and Antoinette Moran and has published in prestigious journals such as Diabetes Care, Cochrane Database of Systematic Reviews and The American Journal of Medicine.

In The Last Decade

Gary M. Onady

19 papers receiving 677 citations

Hit Papers

Clinical Care Guidelines for Cystic Fibrosis–Related Diab... 2010 2026 2015 2020 2010 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary M. Onady United States 10 500 157 106 96 77 22 703
Carol Brunzell United States 5 404 0.8× 161 1.0× 157 1.5× 68 0.7× 58 0.8× 7 557
Alicia Padilla‐Galo Spain 16 587 1.2× 57 0.4× 15 0.1× 52 0.5× 26 0.3× 54 730
Elpis Hatziagorou Greece 13 554 1.1× 70 0.4× 24 0.2× 18 0.2× 64 0.8× 89 731
Anne Burden United Kingdom 17 997 2.0× 137 0.9× 21 0.2× 91 0.9× 14 0.2× 27 1.3k
Kirtisudha Mishra India 12 78 0.2× 84 0.5× 15 0.1× 55 0.6× 25 0.3× 34 484
Samuel N Uwaezuoke Nigeria 15 81 0.2× 42 0.3× 33 0.3× 15 0.2× 19 0.2× 70 604
Grzegorz Telega United States 13 41 0.1× 236 1.5× 21 0.2× 83 0.9× 48 0.6× 30 677
Marzena Krawiec United States 13 1.4k 2.9× 90 0.6× 10 0.1× 95 1.0× 54 0.7× 23 1.9k
Ewa Toporowska‐Kowalska Poland 14 40 0.1× 156 1.0× 77 0.7× 158 1.6× 27 0.4× 51 541
Kathleen Harden United States 12 185 0.4× 173 1.1× 7 0.1× 56 0.6× 8 0.1× 29 691

Countries citing papers authored by Gary M. Onady

Since Specialization
Citations

This map shows the geographic impact of Gary M. Onady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary M. Onady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary M. Onady more than expected).

Fields of papers citing papers by Gary M. Onady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary M. Onady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary M. Onady. The network helps show where Gary M. Onady may publish in the future.

Co-authorship network of co-authors of Gary M. Onady

This figure shows the co-authorship network connecting the top 25 collaborators of Gary M. Onady. A scholar is included among the top collaborators of Gary M. Onady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary M. Onady. Gary M. Onady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Onady, Gary M. & Adrienne Stolfi. (2020). Drug treatments for managing cystic fibrosis-related diabetes. Cochrane Database of Systematic Reviews. 2020(10). CD004730–CD004730. 15 indexed citations
2.
Onady, Gary M. & Adrienne Stolfi. (2016). Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database of Systematic Reviews. 4. CD004730–CD004730. 27 indexed citations
3.
Onady, Gary M. & Adrienne Stolfi. (2013). Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database of Systematic Reviews. CD004730–CD004730. 10 indexed citations
4.
Onady, Gary M., et al.. (2011). Sharing “Moral Space”: Ethical Caveats for the PNP Hospitalist. Journal of Pediatric Health Care. 25(3). 198–202.
5.
Moran, Antoinette, Carol Brunzell, Richard Cohen, et al.. (2010). Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes. Diabetes Care. 33(12). 2697–2708. 462 indexed citations breakdown →
6.
Onady, Gary M.. (2009). Evidence-based Medicine: Applying Valid Evidence. Pediatrics in Review. 30(8). 317–322. 1 indexed citations
7.
Michail, Sonia, Adrienne Stolfi, Thomas Johnson, & Gary M. Onady. (2008). Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. Annals of Allergy Asthma & Immunology. 101(5). 508–516. 71 indexed citations
8.
Onady, Gary M., et al.. (2007). Evidence-based Medicine: Critical Appraisal of the Literature (Critical Appraisal Tools). Pediatrics in Review. 28(4). 132–138. 5 indexed citations
9.
Onady, Gary M., et al.. (2006). An adult cystic fibrosis patient presenting with persistent dyspnea: case report. BMC Pulmonary Medicine. 6(1). 9–9. 25 indexed citations
10.
Onady, Gary M., et al.. (2006). Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study. BMC Endocrine Disorders. 6(1). 4–4. 24 indexed citations
11.
Onady, Gary M. & Adrienne Stolfi. (2005). Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database of Systematic Reviews. CD004730–CD004730. 12 indexed citations
12.
Onady, Gary M., et al.. (2004). Evidence-based Medicine. Pediatrics in Review. 25(10). 358–363. 8 indexed citations
13.
Onady, Gary M., et al.. (2004). Evidence-based Medicine. Pediatrics in Review. 25(10). 358–363. 2 indexed citations
14.
Onady, Gary M., et al.. (2003). Evidence-based Medicine: Asking The Answerable Question (Question Templates as Tools). Pediatrics in Review. 24(8). 265–268. 9 indexed citations
15.
Onady, Gary M., et al.. (2003). Evidence-based Medicine. Pediatrics in Review. 24(8). 265–268.
16.
Onady, Gary M., et al.. (2002). Evidence-based Medicine for the Pediatrician. Pediatrics in Review. 23(9). 318–322. 6 indexed citations
17.
Onady, Gary M., et al.. (2002). Evidence-based Medicine for the Pediatrician. Pediatrics in Review. 23(9). 318–322. 1 indexed citations
18.
Onady, Gary M.. (1997). A community collaborative practice experience between med/peds and family practice. The American Journal of Medicine. 102(5). 441–448. 5 indexed citations
19.
Onady, Gary M.. (1996). Med-peds–three decades of the generic primary care physician. Academic Medicine. 71(11). 1144–5. 4 indexed citations
20.
Reynolds, P. Preston, Angelo P. Giardino, Gary M. Onady, & Eugenia L. Siegler. (1994). Collaboration in the preparation of the generalist physician. Journal of General Internal Medicine. 9(S1). S55–S63. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026